A prescription for power – China's biotech boom and the new global…
How technology could cut millions of hospital visits across Europe
Remote care technology is becoming a critical solution to mounting capacity pressures
China: the next Pfizer will be Chinese
We believe that the next Pfizer will be Chinese
The balance of power in the global pharmaceutical industry is shifting east
South Korea: Asia’s second innovation engine
India: from generics giant to innovation powerhouse?
Japan: Asia's Europe?
Makary's successor faces tough task managing FDA amid budget cuts
Trump's 100% pharma tariffs will have a limited effect on the sector
Watch: European pharma's fight to stay relevant
European pharma's fight to stay relevant
Transformative or overhyped? The impact of weight-loss drugs on European food…
The impact of weight-loss drugs on food demand is still limited in Europe. The need for food companies to adapt will increase as the use of GLP-1s grows
Europe’s last chance to revive its pharmaceutical innovation power
Europe's pharma industry can be a powerhouse again, but it needs to act fast
Pharma’s Godfather moment: pulled back into tariff uncertainty
Dutch healthcare sector set to expand further despite supply constraints
ING Think has analysts all over the world who write about their dedicated region.
Listen: Pharma 2026 - higher prices, manufacturing migration, China's…
Pharma’s 2026 hit list: The White Album
Pharma's 2026 hit list: The White Album
Money (That's What I Want): 2026 is the year of truth for Trump’s…
